Counterpart Health Expands HEDIS Excellence Flywheel to Third‑Party Partners

CLOV
October 15, 2025
Counterpart Health, a wholly owned subsidiary of Clover Health Investments, Corp., announced today that its AI‑driven platform has once again powered top‑tier HEDIS results for Clover Health’s Medicare Advantage plans and is now making this platform available to third‑party partners for the first time. The company’s flywheel has consistently delivered superior outcomes for Clover’s Medicare Advantage population, with patients seeing CA‑powered providers more likely to meet quality benchmarks on colorectal cancer screening, breast cancer screening, and diabetic eye exams. Clover Health remains the #1 performing PPO plan in the country for HEDIS clinical quality measures for plans over 2,000 members. By opening its HEDIS excellence flywheel to external partners, Counterpart Health positions itself to scale the same proven processes that drove Clover’s industry‑leading results, creating a new high‑margin revenue stream and expanding its market reach beyond its own MA plans. The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.